Related Party Transactions (Details Narrative) - USD ($) $ / shares in Units, $ in Millions |
1 Months Ended | ||||
---|---|---|---|---|---|
Jan. 25, 2021 |
Aug. 19, 2020 |
Oct. 10, 2019 |
Jan. 31, 2021 |
Apr. 30, 2022 |
|
Stock Issued During Period, Shares, New Issues | 7,711,284 | 4,608,589 | |||
Sale of Stock, Price Per Share | $ 5.45 | $ 3.25 | |||
China Grand Pharmaceutical [Member] | |||||
Stock Issued During Period, Shares, New Issues | 3,389,198 | 1,999,000 | |||
Sirtex Medical US Holdings Inc [Member] | |||||
Stock Issued During Period, Shares, New Issues | 677,839 | 399,800 | |||
Sirtex [Member] | |||||
Stock Issued During Period, Shares, New Issues | 281,968 | ||||
Non refundable payment | $ 5.0 | ||||
Additional non-refundable and non-creditable if the option is exercised | 25.0 | ||||
Cash to be received if the option is exercised | 20.0 | ||||
Common share to be issued, if the option are exercised | $ 5.0 | ||||
Ownership percentage | 8.00% | ||||
Liability under co-promotion agreement related party | $ 5.0 |
X | ||||||||||
- Definition Additional non-refundable and non-creditable if the option is exercised. No definition available.
|
X | ||||||||||
- Definition Cash to be received if option exercises. No definition available.
|
X | ||||||||||
- Definition Common shares to be issued if option exercises No definition available.
|
X | ||||||||||
- Definition Liability under co-promotion agreement related party. No definition available.
|
X | ||||||||||
- Definition Non-refundable payment. No definition available.
|
X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|